Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
((R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-(nicotinoyloxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycine
ID: ALA5287717
Max Phase: Preclinical
Molecular Formula: C32H46N2O6
Molecular Weight: 554.73
Associated Items:
This compound is not in our inventory system